Psilera Gains Momentum with USF Research Foundation's Support
![Psilera Gains Momentum with USF Research Foundation's Support](https://investorshangout.com/images/blog/ihnews-Psilera%20Gains%20Momentum%20with%20USF%20Research%20Foundation%27s%20Support.jpg)
Psilera Secures Funding to Enhance FTD Research
Psilera, a pioneering biotechnology firm, is setting out to transform the realm of at-home care for challenging neurological ailments, specifically aiming to tackle frontotemporal dementia (FTD). Founded in 2019 by USF Alumni Chris Witsowski, Ph.D., and Jackie von Salm, Ph.D., the company is focused on its mission to revolutionize patient care.
Investment from USF Research Foundation
Recently, Psilera announced an investment of $200,000 from the University of South Florida (USF) Research Foundation. This financial backing continues a productive collaboration between Psilera and USF, and the funds will significantly propel ongoing research into neurodegenerative disorders.
Focus on Innovative Therapies
Psilera's leading candidate, PSIL-006, is a groundbreaking therapy specifically designed to alleviate psychological difficulties associated with frontotemporal dementia. FTD is a progressive disease affecting both cognitive function and behavior, posing significant challenges for both patients and families.
Commitment to Patient-Centered Research
Chris Witsowski, the CEO and co-founder of Psilera, expressed pride in receiving support from the USF Research Foundation, affirming their strong partnership. He stated, "USF has always encouraged companies like ours to explore the boundaries of science for the benefit of patients. This investment enables us to continue our patient-centric research initiatives that can bring about real change."
Support from USF Research Foundation Leadership
Dr. Sylvia Thomas, the President and CEO of the USF Research Foundation, echoed the sentiment of support, highlighting that Psilera's patient-centered approach holds promise for improving the quality of life for many individuals and families affected by debilitating conditions.
Positive Preclinical Findings
Exciting results from recent preclinical studies indicate that PSIL-006 not only addresses psychiatric symptoms but also enhances learning, memory, and normalizes sleep patterns in relevant models, showcasing its multifaceted potential in treating FTD and related conditions.
About Psilera
Psilera stands at the forefront of developing innovative therapeutics for neurological and neurodegenerative diseases. With a steadfast commitment to improving patient experiences through scientific advancements, Psilera aims to significantly impact the lives of individuals facing these challenging medical conditions. They are ushering in a new era of dedicated mental health treatment.
Frequently Asked Questions
What is Psilera's primary focus?
Psilera focuses on developing innovative therapies for neurological and neurodegenerative diseases, particularly aiming to improve patient care.
How much funding did Psilera receive from USF?
Psilera received an investment of $200,000 from the USF Research Foundation to support their research initiatives.
What is PSIL-006?
PSIL-006 is Psilera's lead clinical candidate aimed at alleviating psychological symptoms of frontotemporal dementia.
Why is FTD significant to Psilera?
FTD is a debilitating condition that significantly impacts cognition and behavior, representing a critical area where Psilera aims to make a substantial difference in patient care.
Who co-founded Psilera?
Psilera was co-founded by USF Alumni Chris Witsowski, Ph.D., and Jackie von Salm, Ph.D., in 2019.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Seagram's Vodka Partners with USO to Support Military Families
- Powell Max Limited IPO Raises $5.7 Million with PMAX Shares
- Uphold Launches FDIC-Insured USD Interest Accounts with High APY
- Citi Analysts Predict Major Margin Gains for Intel
- Colts Enhance Performance with New Matrix Helix Turf Upgrade
- Transforming Pediatric Mental Health Care with CBT Scholarships
- Celebrating a Legacy: Mom's Meals Takes a Stand Against Hunger
- Orange Liberia and ZTE Enhance Rural Connectivity with New Sites
- Wolfe Research Highlights Favorable Risk-Reward for Google Stock
- Innovative Partnership Set to Transform Gaming with Blockchain
Recent Articles
- Seagram's Vodka Partners with USO to Support Military Families
- U.S. Banking Sector Sees Profit Surge Amid Expense Reductions
- Powell Max Limited IPO Raises $5.7 Million with PMAX Shares
- JPMorgan Analyzes Equity and Credit Markets Amid Recession Fears
- Understanding the Impact of Stock Splits on Tech Stocks
- Exploring Roth Contributions for Retirement Planning in Your 50s
- Unlocking Profitable Investment Strategies for Success
- Discovering Environmental Stories in the Rural South
- Services Sector Shows Modest Growth Amid Economic Pressures
- Axoni Achieves Prestigious Award for Operational Risk Excellence
- White Lodging Achieves High Ranking in Guest Satisfaction
- Understanding Insurance Fraud: Charges and Legal Consequences
- Surge in Automotive Telematics Market Fuels Innovation and Growth
- BRG Welcomes Investment Arbitration Expert Michael Seelhof
- The Future of Baby Diapers: A Market Set for Expansion
- Eclipse Corporation Launches Testing for Revolutionary DocOrigin Cloud
- Uphold Launches FDIC-Insured USD Interest Accounts with High APY
- Navigating the Surge in Data Center Demand and Investments
- Govee Launches Groundbreaking Smart Lighting Products at IFA 2024
- Nokia Shines as Leader in 2024 Gartner Magic Quadrant for 5G
- Crafting a Future: The Transforming Beer Market Landscape
- Exploring the Surge: Streaming Analytics Market Growth Ahead
- Investigation into Better Choice Company Inc. by Ademi LLP
- Top U.S. Cities for Young Veterans Seeking Affordable Homes
- Nichad Davis Honored Again as National Black Lawyer's Top 40 Under 40
- Is CrossFirst Bankshares Getting a Fair Deal? An Investigation
- Subaru Achieves Highest Satisfaction Scores in Recent Survey
- Transforming Communication: ZTE and Orange Liberia Unite
- FASTSIGNS Achieves Record Attendance at Annual Sales Summit
- Join Investors and Companies at Benzinga's SmallCap Conference
- Investigation Launched on Fair Price for Frontier Communications
- 3M Xtract Cubitron II Film Disc 775L: A Decade of Innovation
- Ghana's Strategic Move: Restructuring $13 Billion in Bonds
- Citi Analysts Predict Major Margin Gains for Intel
- Utz Brands Adjusts Financial Forecast Amid Market Changes
- Applied Digital's Stock Soars After Major Funding Announcement
- Navigating the Recent US Stock Market Trends and Insights
- Insight into Baltic Horizon Fund's Sustainability Practices
- Baltic Horizon Fund's Commitment to Sustainable Investing
- Powell Max Limited Sets Price for Initial Share Offering
- Colts Enhance Performance with New Matrix Helix Turf Upgrade
- Innovative Eco-Friendly Writing Solutions from Tom's Studio
- Transforming Pediatric Mental Health Care with CBT Scholarships
- Xiao-I Corporation Expects 25% Revenue Growth in 2024
- Celebrating Global Impact: HHRD's Charitable Outreach Initiative
- Lincoln the Lawyer Unveils Debut Album 'Interludes'
- Endeavor 3D Secures ITAR Status to Boost Defense Manufacturing
- Celebrating a Legacy: Mom's Meals Takes a Stand Against Hunger
- ams OSRAM and LEDVANCE Forge a Bright Future Together
- Orange Liberia and ZTE Enhance Rural Connectivity with New Sites